Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update.
Ontology highlight
ABSTRACT: In the last two years, the world encountered the SARS-CoV-2 virus, which is still dominating the population due to the absence of a viable treatment. To eradicate the global pandemic, scientists, doctors, and researchers took an exceptionally significant initiative towards the development of effective therapeutics to save many lifes. This review discusses about the single-domain antibodies (sdAbs), also called nanobodies, their structure, and their types against the infections of dreadful SARS-CoV-2 virus. A precise description highlights the nanobodies and their therapeutic application against the other selected viruses. It aims to focus on the extraordinary features of these antibodies compared to the conventional therapeutics like mAbs, convalescent plasma therapy, and vaccines. The sta
SUBMITTER: Bhattacharya M
PROVIDER: S-EPMC9797221 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA